Bilimsel çalışmalar

Prof. Dr. Meral Beksaç

911 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): Therapy induced changes and effects on survival

    Leukemia and Lymphoma, 2004

    DOI 10.1080/1042819032000159915 PMID 15359999 52 atıf (Europe PMC) Kaynak: ORCID

  2. Both higher level of (bcr,abl) transcripts and high Hasford risk score are associated with cytogenetic response but absence of molecular remission during first line use of imatinib mesilate(IM): A finding not observed following use among interferon failures

    Blood, 2004

    Kaynak: ORCID

  3. Case-controlled comparative analysis of ablative and reduced-intensity allogeneic haematopoietic stem cell transplantation in standard risk CML

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  4. Does donor/recipient parity have any impact on graft-versus-host disease? The results of a single-centre retrospective multivariate analysis

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  5. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

    Transfusion and Apheresis Science, 2004

    DOI 10.1016/j.transci.2004.02.003 PMID 15172621 32 atıf (Europe PMC) Kaynak: ORCID

  6. Factors influencing the outcome of HLA-identical sibling transplants for chronic myeloid leukaemia: collaborative analysis from three centres in Poland and Turkey

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  7. High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  8. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

    Journal of Viral Hepatitis, 2004

    DOI 10.1046/j.1365-2893.2003.00479.x PMID 14996349 60 atıf (Europe PMC) Kaynak: ORCID

  9. Occurrence of cytomegalovirus infection and/or viraemia shortens overall survival

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  10. The comparison of myeloablative versus reduced intensity conditioning regimen in ABO mismatched allogeneic hematopoietic cell transplantation

    Blood, 2004

    Kaynak: ORCID

  11. The impact of HLA-dr antigens on chronic graft-versus-host disease associated oral lichenoid lesions

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  12. The outcome of patients with an identified HLA identical sibling donor:: impact of transplantation rate on early transplant outcome

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  13. The use of low molecular weight heparins (dalteparin) for prophylaxis against thromboembolic complications during allogeneic haematopoetic stem cell transplantation

    Bone Marrow Transplantation, 2004

    Kaynak: ORCID

  14. Akut Miyeloid Lösemi

    2004

    Kaynak: OpenAlex

  15. A retrospective comparison of oral versus intravenous administration of busulfan

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  16. Allogeneic Hematopoietic Stem Cell Transplantation in chronic myelogenous leukemia: Comparison of ablative and reduced intensity conditioning regimen

    Blood, 2003

    Kaynak: ORCID

  17. Autologous platelet collection and storage to support thrombocytopenia in a leukemia patient with platelet alloimmunization undergoing chemotherapy

    Turkish Journal of Haematology, 2003

    PMID 27263520 1 atıf (OpenAlex) Kaynak: ORCID

  18. Comparative analysis of molecular response following interferon-alpha, imatinib mesilate or allogeneic stem cell transplantation (ASCT): best response is obtained with ASCT in chronic myeloid leukemia

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  19. Comparison of mobilized peripheral blood progenitor cells and bone marrow transplantation to HLA-identical siblings with standard-risk leukaemia: long term follow-up

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  20. Comparison of three conditioning regimens used in high-dose therapy of malign lymphomas: CBV-ICE-CTM

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  21. Differences between graft product and donor side effects following bone marrow or stem cell donation

    Bone Marrow Transplantation, 2003

    DOI 10.1038/sj.bmt.1704245 PMID 14561987 69 atıf (Europe PMC) Kaynak: ORCID

  22. Donor type epithelial cell repopulation in gastrointestinal mucosa following sex mismatch allogeneic peripheral blood transplantation: evidence for in vivo stem cell plasticity?

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  23. Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease:: Turkish experience

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  24. Fetal-obstetric parameters that decrease volume (V) or mononuclear cell content (MNC) do not influence total hematopoietic cell content (HSCC) in the cord blood (CB) harvest

    Blood, 2003

    Kaynak: ORCID

  25. Hyperkeratosis of the Nipple Associated with Chronic Graft versus Host Disease after Allogeneic Haematopoietic Cell Transplantation [8]

    Acta Dermato-Venereologica, 2003

    DOI 10.1080/00015550310012665 PMID 14609115 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  26. In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA)

    Blood, 2003

    Kaynak: ORCID

  27. Kinetics of chimerism in sex-mismatched allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  28. Long-term evaluation of hematopoietic and immune reconstitution following allogeneic peripheral blood hematopoietic cell transplantation during graft-versus-host disease

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  29. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, 2003

    DOI 10.1182/blood-2003-03-0665 PMID 12829583 42 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  30. Reduction of stem cell content is a feasible approach in standard risk HLA identical sibling allogeneic peripheral or marrow transplants

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  31. Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): Results from three Turkish transplant centers

    Bone Marrow Transplantation, 2003

    DOI 10.1038/sj.bmt.1703930 PMID 12748666 2 atıf (Europe PMC) Kaynak: ORCID

  32. The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia

    Leukemia and Lymphoma, 2003

    DOI 10.1080/1042819031000067512 PMID 12802915 6 atıf (Europe PMC) Kaynak: ORCID

  33. The effect of hepatitis B virus status of donor on the hepatitis B virus serology of recipient after allogeneic hematopoietic cell transplantation

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  34. The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation

    Journal of Hepatology, 2003

    DOI 10.1016/s0168-8278(03)80768-7 Kaynak: ORCID

  35. The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  36. The highest doses of alkylating agents administered during hematopoietic stem cell transplantation

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  37. The relation between T-helper subsets and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    Bone Marrow Transplantation, 2003

    Kaynak: ORCID

  38. Tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), interleukin-10 (IL-10), transforming growth factor-beta (TGF-beta) and interferon-gamma (INF-gamma) polymorphic single nucleotide allele frequencies in patients with multiple myeloma (MM): Disparities between the siblings and effect on treatment outcome

    Blood, 2003

    Kaynak: ORCID

  39. Feature extraction and classification of blood cells for an automated differential blood count system

    International Joint Conference on Neural Networks (IJCNN), 2002

    DOI 10.1109/ijcnn.2001.938753 72 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  40. A retrospective comparison of oral versus intravenous administration of Busulfan: Preliminary results show similar toxicity but less relapse

    Bone Marrow Transplantation, 2002

    Kaynak: ORCID

  41. Analysis of high and low risk chronic myeloid leukemia by gene expression profiling

    Blood, 2002

    Kaynak: ORCID

  42. Does donor recipient ABO-incompatibility have any effect on the course and outcome of allogeneic hematopoietic cell transplantation?

    Bone Marrow Transplantation, 2002

    Kaynak: ORCID

  43. Extramedullary presentation of biclonal IgGκ and IgAκ multiple myeloma

    Turkish Journal of Haematology, 2002

    PMID 27264980 1 atıf (OpenAlex) Kaynak: ORCID

  44. HLA-A1 is associated with CMV viremia in recipients of hematopoietic stem cell transplants from seropositive donors

    Tissue Antigens, 2002

    Kaynak: ORCID

  45. In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

    Medical Oncology, 2002

    DOI 10.1385/mo:19:1:59 PMID 12025892 6 atıf (Europe PMC) Kaynak: ORCID

  46. Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers

    Therapeutic Apheresis, 2002

    DOI 10.1046/j.1526-0968.2002.00319.x PMID 11886581 4 atıf (Europe PMC) Kaynak: ORCID

  47. Is there a correlation between peripheral blood CD34+cells and peripheral blood erythrocyte precursors in healthy G-CSF stimulated donors and the effect of G-CSF and apheresis on complete blood count

    Bone Marrow Transplantation, 2002

    Kaynak: ORCID

  48. Late non-relapse mortality after allogeneic hematopoietic cell transplantation: the impact of bronchiolitis obliterans

    Bone Marrow Transplantation, 2002

    Kaynak: ORCID

  49. Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation.: A single institutional experience

    Blood, 2002

    Kaynak: ORCID

  50. Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction.: Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002)

    Blood, 2002

    Kaynak: ORCID